tradingkey.logo

Seer Inc

SEER
查看详细走势图
1.790USD
-0.030-1.65%
收盘 12/19, 16:00美东报价延迟15分钟
99.86M总市值
亏损市盈率 TTM

Seer Inc

1.790
-0.030-1.65%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-1.65%

5天

+1.70%

1月

-10.50%

6月

-9.60%

今年开始到现在

-22.51%

1年

-22.84%

查看详细走势图

TradingKey Seer Inc股票评分

单位: USD 更新时间: 2025-12-19

操作建议

Seer Inc当前公司基本面数据相对非常健康,增长潜力稳定。当前估值合理,在办公设备行业排名6/7位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价3.00。中期看,股价处于下降通道。近一个月,市场表现较差,基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间,可以做区间波段操作。

Seer Inc评分

相关信息

行业排名
6 / 7
全市场排名
270 / 4582
所属行业
办公设备

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 1 位分析师
买入
评级
3.000
目标均价
+52.28%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Seer Inc亮点

亮点风险
Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
业绩增长期
公司处于发展阶段,最新年度总收入14.17M美元
估值合理
公司最新PB估值0.37,处于3年历史合理位
机构减仓
最新机构持股32.64M股,环比减少19.98%
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值2.22M

Seer Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Seer Inc简介

Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
公司代码SEER
公司Seer Inc
CEOFarokhzad (Omid C)
网址https://seer.bio/

常见问题

Seer Inc(SEER)的当前股价是多少?

Seer Inc(SEER)的当前股价是 1.790。

Seer Inc的股票代码是什么?

Seer Inc的股票代码是SEER。

Seer Inc股票的52周最高点是多少?

Seer Inc股票的52周最高点是2.510。

Seer Inc股票的52周最低点是多少?

Seer Inc股票的52周最低点是1.620。

Seer Inc的市值是多少?

Seer Inc的市值是99.86M。

Seer Inc的净利润是多少?

Seer Inc的净利润为-86.60M。

现在Seer Inc(SEER)的股票是买入、持有还是卖出?

根据分析师评级,Seer Inc(SEER)的总体评级为买入,目标价格为3.000。

Seer Inc(SEER)股票的每股收益(EPS TTM)是多少

Seer Inc(SEER)股票的每股收益(EPS TTM)是-1.361。
KeyAI